During the past decade, Mater Hospital Brisbane (Inflammatory Bowel Diseases) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mater Hospital Brisbane (Inflammatory Bowel Diseases)" are "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Mater Hospital Brisbane (Inflammatory Bowel Diseases)" in a lesser frequency.

Most popular intervention types in "Mater Hospital Brisbane (Inflammatory Bowel Diseases)" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab (40 mg)" (1 trials), "Golimumab" (1 trials), "Golimumab Dose 1" (1 trials) and "Golimumab Dose 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mater Hospital Brisbane (Inflammatory Bowel Diseases)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mater Hospital Brisbane (Inflammatory Bowel Diseases)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mater Hospital Brisbane (Inflammatory Bowel Diseases), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mater Hospital Brisbane (Inflammatory Bowel Diseases), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".